Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury - (NOSTRA Phase III Trial): A Confirmatory, Placebo-controlled, Randomised, Double Blind, Multi-centre Study

Next Previous
Trial Profile

Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury - (NOSTRA Phase III Trial): A Confirmatory, Placebo-controlled, Randomised, Double Blind, Multi-centre Study

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ronopterin (Primary) ; Ronopterin (Primary)
  • Indications Traumatic brain injuries
  • Focus Registrational; Therapeutic Use
  • Acronyms NOSTRA-III
  • Sponsors vasopharm BIOTECH

    • Most Recent Events

    • 12 Jul 2022 According to a vasopharm BIOTECH media release, data from this study will be presented at the 15th International Neurotrauma Symposium
    • 12 Jul 2022 Results of post hoc analyses of clinical trials (NOSTRA and NOSTRA-III), published in the vasopharm BIOTECH Media Release
    • 10 May 2022 Results published in the vasopharm BIOTECH Media Release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top